[en] Dual-specificity phosphatase 3 (DUSP3) is a small phosphatase with poorly known physiological functions and for which only a few substrates are known. Using DUSP3-deficient mice, we recently reported that DUSP3 deficiency confers resistance to endotoxin- and polymicrobial-induced septic shock. We showed that this protection was macrophage dependent.
In this study, we further investigated the role of DUSP3 in sepsis tolerance and showed that the resistance is sex dependent. Using adoptive-transfer experiments and ovariectomized mice, we highlighted the role of female sex hormones in the phenotype. Indeed, in ovariectomized female and male mice, the dominance of M2-like macrophages observed in DUSP32/2 female mice was reduced,
suggesting a role for this cell subset in sepsis tolerance. At the molecular level, DUSP3 deletion was associated with estrogen dependent decreased phosphorylation of ERK1/2 and Akt in peritoneal macrophages stimulated ex vivo by LPS. Our results demonstrate that estrogens may modulate M2-like responses during endotoxemia in a DUSP3-dependent manner.
Disciplines :
Immunology & infectious disease
Author, co-author :
Vandereyken, Maud
Singh, Pratibha
Wathieu, Caroline ; Université de Liège > Département de pharmacie > Chimie médicale
Jacques, Sophie ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Singer, M., C. S. Deutschman, C. W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, G. R. Bernard, J. D. Chiche, C. M. Coopersmith, et al. 2016. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315: 801-810.
Rittirsch, D., M. A. Flierl, and P. A.Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8: 776-787.
Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
Seeley, E. J., M. A. Matthay, and P. J. Wolters. 2012. Inflection points in sepsis biology: From local defense to systemic organ injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L355-L363.
Angele, M. K., S. Pratschke, W. J. Hubbard, and I. H. Chaudry. 2014. Gender differences in sepsis: Cardiovascular and immunological aspects. Virulence 5: 12-19.
Ishibashi, T., D. P. Bottaro, A. Chan, T. Miki, and S. A. Aaronson. 1992. Expression cloning of a human dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 89: 12170-12174.
Yuvaniyama, J., J. M. Denu, J. E. Dixon, and M. A. Saper. 1996. Crystal structure of the dual specificity protein phosphatase VHR. Science. 272: 1328-1331.
Alonso, A., M. Saxena, S. Williams, and T. Mustelin. 2001. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J. Biol. Chem. 276: 4766-4771.
Todd, J. L., J. D. Rigas, L. A. Rafty, and J. M. Denu. 2002. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK). Oncogene 21: 2573-2583.
Todd, J. L., K. G. Tanner, and J. M. Denu. 1999. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity proteintyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway. J. Biol. Chem. 274: 13271-13280.
Wang, J. Y., C. L. Yeh, H. C. Chou, C. H. Yang, Y. N. Fu, Y. T. Chen, H. W. Cheng, C. Y. Huang, H. P. Liu, S. F. Huang, and Y. R. Chen. 2011. Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer. J. Biol. Chem. 286: 10177-10184.
Hoyt, R., W. Zhu, F. Cerignoli, A. Alonso, T. Mustelin, and M. David. 2007. Cutting edge: Selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase. J. Immunol. 179: 3402-3406.
Amand, M., C. Erpicum, K. Bajou, F. Cerignoli, S. Blacher, M. Martin, F. Dequiedt, P. Drion, P. Singh, T. Zurashvili, et al. 2014. DUSP3/VHR is a proangiogenic atypical dual-specificity phosphatase. Mol. Cancer 13: 108.
Musumeci, L., M. J. Kuijpers, K. Gilio, A. Hego, E. Théâtre, L. Maurissen, M. Vandereyken, C. V. Diogo, C. Lecut, W. Guilmain, et al. 2015. Dualspecificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis. Circulation 131: 656-668.
Singh, P., L. Dejager, M. Amand, E. Theatre, M. Vandereyken, T. Zurashvili, M. Singh, M. Mack, S. Timmermans, L. Musumeci, et al. 2015. DUSP3 genetic deletion confers M2-like macrophage-dependent tolerance to septic shock. J. Immunol. 194: 4951-4962.
Amand, M., C. Erpicum, C. Gilles, A. Noel, and S. Rahmouni. 2016. Functional analysis of dual specificity phosphatases in angiogenesis. Methods Mol Biol 1447: 331-349.
Pavic, K., G. Duan, and M. Köhn. 2015. VHR/DUSP3 phosphatase: Structure, function and regulation. FEBS J. 282: 1871-1890.
Alonso, A., S. Rahmouni, S. Williams, M. van Stipdonk, L. Jaroszewski, A. Godzik, R. T. Abraham, S. P. Schoenberger, and T. Mustelin. 2003. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat. Immunol. 4: 44-48.
Rittirsch, D., M. S. Huber-Lang, M. A. Flierl, and P. A.Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4: 31-36.
Klein, S. L. 2012. Immune cells have sex and so should journal articles. Endocrinology 153: 2544-2550.
Verthelyi, D. 2001. Sex hormones as immunomodulators in health and disease. Int. Immunopharmacol. 1: 983-993.
Hotchkiss, R. S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13: 862-874.
Ghosn, E. E., A. A. Cassado, G. R. Govoni, T. Fukuhara, Y. Yang, D. M. Monack, K. R. Bortoluci, S. R. Almeida, L. A. Herzenberg, and L. A. Herzenberg. 2010. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc. Natl. Acad. Sci. USA 107: 2568-2573.
Rahmouni, S., F. Cerignoli, A. Alonso, T. Tsutji, R. Henkens, C. Zhu, C. Louisdit-Sully, M. Moutschen, W. Jiang, and T. Mustelin. 2006. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nat. Cell Biol. 8: 524-531.
Laird, M. H., S. H. Rhee, D. J. Perkins, A. E. Medvedev, W. Piao, M. J. Fenton, and S. N. Vogel. 2009. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J. Leukoc. Biol. 85: 966-977.
Straub, R. H. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28: 521-574.
Suarez De La Rica, A., F. Gilsanz, and E. Maseda. 2016. Epidemiologic trends of sepsis in western countries. Ann. Transl. Med. 4: 325.
Shankar-Hari, M., M. Ambler, V. Mahalingasivam, A. Jones, K. Rowan, and G. D. Rubenfeld. 2016. Evidence for a causal link between sepsis and long-term mortality: A systematic review of epidemiologic studies. Crit. Care 20: 101.
Beery, T. A. 2003. Sex differences in infection and sepsis. Crit. Care Nurs. Clin. North Am. 15: 55-62.
Wichmann, M. W., D. Inthorn, H. J. Andress, and F. W. Schildberg. 2000. Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome. Intensive Care Med. 26: 167-172.
Angele, M. K., M. G. Schwacha, A. Ayala, and I. H. Chaudry. 2000. Effect of gender and sex hormones on immune responses following shock. Shock 14: 81-90.
Tsuyuguchi, K., K. Suzuki, H. Matsumoto, E. Tanaka, R. Amitani, and F. Kuze. 2001. Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice. Clin. Exp. Immunol. 123: 428-434.
Leone, M., J. Textoris, C. Capo, and J. Mege. 2012. Sex hormones and bacterial infections. In Sex Hormones. R. Dubey, ed. InTech, Rijeka, Croatia. Available at: Https://www.intechopen.com/books/sex-hormones/sex-hormones-and-bacterialinfections.
Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
Fairweather, D., and D. Cihakova. 2009. Alternatively activated macrophages in infection and autoimmunity. J. Autoimmun. 33: 222-230.
Bolego, C., A. Cignarella, B. Staels, and G. Chinetti-Gbaguidi. 2013. Macrophage function and polarization in cardiovascular disease: A role of estrogen signaling?. Arterioscler. Thromb. Vasc. Biol. 33: 1127-1134.
Ribas, V., B. G. Drew, A. Le, T. Soleymani, P. Daraei, D. Sitz, D. C. Henstridge, M. A. Febbraio, S. C. Hewitt, K. S. Korach, et al. 2011. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. [Published erratum appears in 2012 Proc. Natl. Acad. Sci. USA 109: 645.] Proc. Natl. Acad. Sci. USA 108: 16457-16462.
Carreras, E., S. Turner, M. B. Frank, N. Knowlton, J. Osban, M. Centola, C. G. Park, A. Simmons, J. Alberola-Ila, and S. Kovats. 2010. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115: 238-246.
Angele, M. K., M. W. Knöferl, M. G. Schwacha, A. Ayala, W. G. Cioffi, K. I. Bland, and I. H. Chaudry. 1999. Sex steroids regulate pro- and antiinflammatory cytokine release by macrophages after trauma-hemorrhage. Am. J. Physiol. 277: C35-C42.
Srivastava, S., M. N. Weitzmann, S. Cenci, F. P. Ross, S. Adler, and R. Pacifici. 1999. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 104: 503-513.
Ray, P., S. K. Ghosh, D. H. Zhang, and A. Ray. 1997. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett. 409: 79-85.
Ma, L., Z. Chen, H. Erdjument-Bromage, P. Tempst, and P. P. Pandolfi. 2005. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179-193.
Byles, V., A. J. Covarrubias, I. Ben-Sahra, D. W. Lamming, D. M. Sabatini, B. D. Manning, and T. Horng. 2013. The TSC-mTOR pathway regulates macrophage polarization. Nat. Commun. 4: 2834.
Inoki, K., Y. Li, T. Zhu, J.Wu, and K. L. Guan. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4: 648-657.
Covarrubias, A. J., H. I. Aksoylar, and T. Horng. 2015. Control of macrophage metabolism and activation by mTOR and Akt signaling. Semin. Immunol. 27: 286-296.